Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 8:00 PM JST
Settings

Settings

Goto Application

Offices all Languages Stemming false Single Family Member true Include NPL false

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:A61K36/00 AND EN_ALLTXT:(coronavirus OR coronaviruses OR coronaviridae OR coronavirinae OR orthocoronavirus OR orthocoronaviruses OR orthocoronaviridae OR orthocoronavirinae OR betacoronavirus OR betacoronaviruses OR betacoronaviridae OR betacoronavirinae OR sarbecovirus OR sarbecoviruses OR sarbecoviridae OR sarbecovirinae OR "severe acute respiratory syndrome" OR sars OR "2019 ncov" OR covid)

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.WO/2021/259772PREPARATIONS CONTAINING BERRY EXTRACTS FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF VIRAL INFECTIONS CAUSED BY CORONAVIRIDAE
WO 30.12.2021
Int.Class A61K 36/45
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
45Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
Appl.No PCT/EP2021/066557 Applicant EVONIK OPERATIONS GMBH Inventor HERBEAUX, Jean-Luc
The present invention is related to compositions for use in treating or preventing a virus infection in a subject, wherein the virus is from the Coronaviridae family and wherein the composition comprises an extract of black currants and/or bilberries.
2.WO/2021/159050COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTION
WO 12.08.2021
Int.Class A61K 31/7048
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7042Compounds having saccharide radicals and heterocyclic rings
7048having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
Appl.No PCT/US2021/017006 Applicant SHI, Yuenian Inventor SHI, Yuenian
Disclosed are low molecular weight heparins, particularly enoxaparin and their use in the treatment of coronavirus infection, in particular 2019-nCov, in a subject. These low molecular weight heparins may be administered to the subject together with another therapeutic agent such as a corticosteroid, an anti-inflammatory signal transduction modulator, a B2-adrenoreceptor agonist bronchodilator, an anticholinergic, a mucolytic agent, hypertonic saline, imatinib mesylate, nilotinib hydrochlorine, dasatinib, interferon, ribavirin, adefovir, tenofovir, acyclovir, brivudine, cidofovir, fomivirsen, foscarnet, ganciclovir, penciclovir, amantadine, rimantadine, zanamivir and remdesivir.
3.20210346453COMPOSITIONS AND METHODS FOR TREATMENT OF COVID-19
US 11.11.2021
Int.Class A61K 36/74
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
74Rubiaceae (Madder family)
Appl.No 17315519 Applicant Cognitive Clarity Inc. Inventor Alan D. Snow

The present disclosure relates generally to methods for treating coronavirus infections (e.g., SARS-CoV-2 infection or COVID-19) in a subject in need thereof comprising administering to the subject a therapeutically effective amount of an Uncaria tomentosa extract.

4.20210308200COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATORY RESPONSE
US 07.10.2021
Int.Class A61K 36/07
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
06Fungi, e.g. yeasts
07Basidiomycota, e.g. Cryptococcus
Appl.No 17221437 Applicant TURTLE BEAR HOLDINGS, LLC Inventor Paul E. STAMETS

Described herein are mushroom compositions and methods for treating, prophylaxis of, or ameliorating symptoms of one or more adverse reactions triggered by an infectious disease or condition that increases an anti-inflammatory response in a subject with such compositions. In one aspect the composition comprises an aqueous or solid fraction of a mycelium, a fermented substrate thereof, or a combination thereof optionally combined with one or more buffering agents, ethanol, and water.

5.WO/2021/191864FOOD SUPPLEMENTS FOR THE PREVENTION OF COVID-19
WO 30.09.2021
Int.Class A61K 36/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Appl.No PCT/IB2021/052534 Applicant DOUND, Yogesh Inventor DOUND, Yogesh
The present invention relates to a food/ nutraceutical supplements for the preventive management of COVID-19. Specifically, the present invention relates to food/ nutraceutical supplements comprising Vitamin K2-7 and/or curcuminoid, especially tetrahydrocurcumin for the preventive management of severe acute respiratory syndrome coronavirus (SARS-CoV) and COVID-19.
6.20210308201COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATORY RESPONSE
US 07.10.2021
Int.Class A61K 36/074
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
06Fungi, e.g. yeasts
07Basidiomycota, e.g. Cryptococcus
074Ganoderma
Appl.No 17221411 Applicant TURTLE BEAR HOLDINGS, LLC Inventor Paul E. STAMETS

Described herein are mushroom compositions and methods for treating, prophylaxis of, or ameliorating symptoms of one or more adverse reactions triggered by an infectious disease or condition that increases an anti-inflammatory response in a subject with such compositions. In one aspect the composition comprises an aqueous or solid fraction of a mushroom mycelium and/or fruit body mixture, optionally combined with one or more buffering agents, ethanol, and water.

7.WO/2021/191886COMPOSITIONS COMPRISING TERPENES AND TERPENOIDS AND USE THEREOF FOR PREVENTING AND TREATING VIRAL-INDUCED INFECTIONS OF THE RESPIRATORY SYSTEM
WO 30.09.2021
Int.Class A61K 36/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Appl.No PCT/IL2021/050218 Applicant EYBNA TECHNOLOGIES LTD. Inventor EYAL, Nadav
Provided herein are compositions comprising a plurality of terpenes terpenoids and uses thereof for preventing viral induced severe acute respiratory syndrome (SARS), reducing the risk of infection and treating viral infections.
8.2021106876FORMULATIONS COMPRISING BOTANICAL EXTRACTS
AU 09.09.2021
Int.Class A61K 36/19
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
19Acanthaceae (Acanthus family)
Appl.No 2021106876 Applicant Apex Biotech Research Pty Ltd Inventor
The application relates to antiviral compositions comprising andrographolide, ursolic acid, and piceid and their use in treatment of viral and bacterial infections (including COVID-19). Combinations of either andrographolide and ursolic acid, or andrographolide and piced are also disclosed. Alternatively, extracts from Andrographis paniculata(for andrographolide), Eriobotrya japonica (for ursolic acid), and Reynoutria japonica (piceid) are used. The combination can additionally comprise other antivirals including monoclonal antibodies.
9.WO/2021/202823THERAPEUTIC TREATMENT FOR THE CORONAVIRUS DISEASE COVID-19
WO 07.10.2021
Int.Class A61K 36/28
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
Appl.No PCT/US2021/025298 Applicant MOLLICK, Peter J. Inventor MOLLICK, Peter J.
A therapeutic treatment for the treatment of COVID-19 disease, the treatment to be initiated soon after and preferably within approximately twenty four hours after the patient develops the first signs of symptoms comprising but not limited to individually or in combination thereof fever, headache, sore joints, cough, fatigue, chills. The treatment consists of the oral administration of the herb thyme, also know as common thyme (Thymus vulgaris). The treatment is thought to inhibit the replication and activity of the virus allowing the patient to regain normal health and assist in developing immunity to the virus. The treatment is not known to completely eliminate the virus from the patient therefore resulting in the patient possibly developing the same or different symptoms of the disease a second, or more times requiring additional treatments of the disclosed thyme therapeutic treatment.
10.WO/2021/089807ANTIVIRAL PREPARATION FROM CHESTNUT SHELLS OF CASTANEA SATIVA MILL
WO 14.05.2021
Int.Class A61K 36/49
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
49Fagaceae (Beech family), e.g. oak or chestnut
Appl.No PCT/EP2020/081329 Applicant MICRONATURE S.R.L. Inventor FRANCI, Gianluigi
The present invention refers to the use of an extract from chestnut shells (CSE), peeling waste of the chestnut, (fruit of the tree Castanea sativa Mill., European Chestnut), or fractions of said extract, with specific antiviral activity in the treatment and/or prevention of Herpesviridae, Retroviridae, and Coronaviridae infections.